Home › NDC Lookup › Ingredients › Terbinafine Hydrochloride › 61047-0120-01
Lamisil AT Cream Terbinafine Hydrochloride 1 g/100g Cream — NDC 61047-0120-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Lamisil AT Cream Terbinafine Hydrochloride 1 g/100g Cream — NDC 61047-120-01 (Billing 61047-0120-01)

by Voyant Beauty Inc. · 1 TUBE in 1 CARTON / 12 g in 1 TUBE

This is a package of Lamisil AT Cream Terbinafine Hydrochloride 1 g/100g Cream from Voyant Beauty Inc., no longer marketed (first marketed Feb 2020), no longer in the FDA NDC Directory. It is the main listing for this product, which comes in 3 package sizes.

NDC 61047-0120-01
🏷️ FDA NDC (as labeled) 61047-120-01 billing pads the product segment with a zero
This package
Contains12 g in 1 tube Pack sizes3 compare ↓
Main listing for product 61047-120 · Also comes in: 12 g 61047-120-02 30 g 61047-120-03
OTC Brand Discontinued Non-controlled ⚠ Discontinued by firm ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 61047-120-01 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
61047 labeler · 120 product · 01 package
Barcode (UPC)
0300673998308, 0300673998421
FDA record last changed
Jul 24, 2026
⚠️
Excluded from the active FDA NDC Directory. The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory. Search the FDA NDC Directory ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 61047-120-01
Product NDC 61047-120
11-digit billing NDC 61047012001
RxCUI 992528, 992530
UNII 012C11ZU6G
UPC 0300673998308, 0300673998421
Application # NDA020980
SPL Set ID 9dea4789-bf1c-1577-e053-2a95a90a5381
Established class (EPC) Allylamine Antifungal
Chemical class Allylamine
DEA schedule Non-controlled
Marketing category NDA
Marketing status Discontinued
FDA listing status Discontinued by firm
Marketing start 2020-02-20
Marketing end 2027-05-31
Route TOPICAL
Dosage form CREAM
Substance TERBINAFINE HYDROCHLORIDE
Quick answers
  • RxCUI (RxNorm): 992528
Why two NDCs? The FDA registers this code as 61047-120-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 61047-0120-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Allylamine Antifungal class.

Pharmacologic class Allylamine Antifungal
Drug family (ATC) Other antifungals for topical use, Antifungals for systemic use
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It depends on the form. The tablets treat fungal infections of the toenails or fingernails. Topical products like Lamisil AT treat athlete’s foot, jock itch and ringworm. Your doct...
  • You take one tablet by mouth once a day, with or without food. Fingernails take a shorter course than toenails. Your nail can look better only after healthy nail grows out, which t...
  • Liver failure has happened with terbinafine tablets, even in people with no liver problems. A blood test before and during treatment helps catch trouble early. Call your doctor rig...
  • Headache, diarrhea, rash, upset stomach and itching are the common ones, and they are usually mild. Call your doctor for taste or smell changes, low mood, blistering or spreading r...
📖 Read our full Terbinafine guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 12 g 30 g
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
61047-0120-01 You're viewing this Main listing 1 TUBE in 1 CARTON / 12 g in 1 TUBE 2020-02-24 — Discontinued by firm
61047-0120-02 61047-120-02 1 TUBE in 1 CARTON / 12 g in 1 TUBE 2020-03-02 — Discontinued by firm
61047-0120-03 61047-120-03 1 TUBE in 1 CARTON / 30 g in 1 TUBE 2020-02-20 May 31, 2027 Active

Pack size FAQ

What quantity is in this package?
This package is listed by the FDA — 1 tube in 1 carton / 12 g in 1 tube.
What NDC number is used to bill for this package of Lamisil AT Cream Terbinafine Hydrochloride 1 g/100g Cream?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Good Neighbor Pharmacy 1 g/100g 24385-0524-03 AmerisourceBergen 1 tube $0.231 — Availability likely —
Terbinafine Hydrochloride 1 g/100g 70677-1003-01 STRATEGIC 1 tube $0.309 — Availability likely —
Terbinafine Hydrochloride 1 g/100g 51672-2080-01 Sun 1 tube $0.398 — Availability likely —
Terbinafine Hydrochloride 1 g/100g 70000-0338-01 Cardinal 1 tube $0.398 — Availability likely —
Walgreens Athletes Foot 1 g/100g 00363-2080-01 Walgreen 1 tube — — FDA listed —
Terbinafine Hydrochloride 1 g/100g 00363-4502-02 WALGREEN 1 tube — — FDA listed —
Athletes Foot 1 g/100g 11822-0080-01 Rite 1 tube — — FDA listed —
Kroger Antifungal 1 g/100g 30142-0080-01 Kroger 1 tube — — FDA listed —
Athletes Foot 1 g/100g 37808-0080-01 H 1 tube — — FDA listed —
Antifungal 1 g/100g 41250-0080-02 Meijer 1 tube — — FDA listed —
equate Athletes Foot 1 g/100g 49035-0080-03 Wal-Mart 1 tube — — FDA listed —
Silka Antifungal 1 g/100g 50066-0080-02 Genomma 1 tube — — FDA listed —
Silka Jock Itch 1 g/100g 50066-0208-05 Genomma 1 tube — — FDA listed —
Terbinafine Hydrochloride 1 g/100g 50090-1278-00 A-S 1 tube — — FDA listed —
Terbinafine Hydrochloride 1 g/100g 50090-5810-00 A-S 1 tube — — FDA listed —
Terbinafine Hydrochloride 1 g/100g 51672-2140-01 Sun 1 tube — — FDA listed —
Athletes Foot 1 g/100g 56062-0080-02 Publix 1 tube — — FDA listed —
CVS Pharmacy Athletes Foot 1 g/100g 59779-0080-01 CVS 1 tube — — FDA listed —
Cvs 1 g/100g 59779-0523-01 CVS 1 tube — — FDA listed —
Lamisil AT Cream 1 g/100gthis 61047-0120-01 Voyant 1 tube — — Discontinued —
Lamisil At Terbinafine Hydrochloride 1 g/100g 61047-0139-01 Voyant 1 tube — — FDA listed —
Terbinafine Hydrochloride 1 g/100g 63187-0111-15 Proficient 1 tube — — FDA listed —
Good Neighbor Pharmacy 1 g/100g 68788-4044-01 Preferred 1 tube — — FDA listed —
Terbinafine Hydrochloride 1 g/100g 68788-9814-01 Preferred 15 g — — FDA listed —
Curist Antifungal Relief 1 g/100g 72559-0035-58 Little 1 tube — — FDA listed —
Terbinafine Hydrochloride 1 g/100g 73469-7215-02 Scholl's 1 tube — — FDA listed —
PHARMBANNER TINEA VERSICOLOR Cream 1 g/100g 83818-0024-01 Shenzhen 60 g — — FDA listed —
Lamisil AT Cream 1 g/100g 84485-3607-01 Karo 1 tube — — FDA listed —
Lamisil AT Cream 1 g/100g 84485-3748-03 Karo 1 tube — — FDA listed —
Lamisil AT Cream 1 g/100g 84485-4030-01 Karo 1 tube — — FDA listed —
Athlete Foot Cream 1 g/100g 85398-0006-01 Beautivity 60 g — — FDA listed —
About this product: this is the brand-name version. FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2020
On the market since
Feb 2020
📍
2026
Currently FDA-listed
6 years listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available

FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerVoyant Beauty Inc.
Application holderKARO HEALTHCARE INC
FDA applicationNDA020980 (NDA)
Labeler code61047
First marketedFeb 2020
Product typeHuman Otc Drug

More NDCs from Voyant Beauty Inc. labeler code 61047

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 23 words ▾

Uses - cure most jock itch (tinea cruris) and ringworm (tinea corporis) - relieves itching, burning, cracking andf scaling which accompany this condition

⏱️ Dosage and Administration 129 words ▾

Directions - adults and children 12 years and over: use the tip of the cap to break the seal and open the tube wash the affected skin with soap and water and dry completely before applying for athlete's foot wear well-fitting, ventilated shoes. Change shoes and socks at least once daily. between the toes only: apply twice a day (morning and night) for 1 week or as directed by a doctor on the bottom or sides of the foot: apply twice a day (morning and night) for 2 weeks or as directed by a doctor for jock itch and ringworm: apply once a day (morning or night) for 1 week or as directed by a doctor wash hands after each use - children under 12 years: ask a doctor

⚠️ Warnings 76 words ▾

Warnings For external use only Do not use - on nails or scalp - in or near the mouth or eyes - for vaginal yeast infections When using this product do not get into eyes. If eye contact occurs, rinse thoroughly with water Stop use and ask a doctor if too much irritation occurs or gets worse Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 4 words ▾

Terbinafine hydrochloride 1% Antifungal

🧪 Inactive Ingredients 20 words ▾

Inactive Ingredients benzyl alcohol, cetyl alcohol, cetyl palmitate, isopropyl myristate, polysorbate 60, purified water, sodium hydroxide, sorbitan monostearate, stearly alcohol

🎯 Purpose 1 words ▾

Antifungal

📄 Do Not Use 21 words ▾

Do not use - on nails or scalp - in or near the mouth or eyes - for vaginal yeast infections

📄 When Using This Product 17 words ▾

When using this product do not get into eyes. If eye contact occurs, rinse thoroughly with water

📄 Stop Use and Ask a Doctor If 14 words ▾

Stop use and ask a doctor if too much irritation occurs or gets worse

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Other Information 24 words ▾

Other Information - do no use if seal on tube is broken or is not visible - store at controlled room temperature 20-25C (68-77F)

📄 Questions or Comments 5 words ▾

Questions or comments? call 1-800-330-9876

📄 Package Label / Principal Display Panel 115 words ▾

12 g Tube with Carton - For Jock Itch Lamisil AT Cream Terbinafine Hydrochloride Cream 1% - Antifungal For JOCK ITCH - cures most jock itch - for effective relief of itching and burning NET WT 12 g (0.42 oz) 12g Tube Jock Itch JI_12g_Carton

12 g Tube with Carton - For Athlete's Foot Lamisil AT Cream Terbinafine Hydrochloride Cream 1% - Antifungal For Athlete's Foot Net Wt 12 g (0.42 oz) 12 g Tube Foot 12 g Carton Foot

30 g Tube with Carton - For Athlete's Foot Lamisil AT Cream Terbinafine Hydrochloride Cream 1% - Antifungal For Athlete's Foot NET WT 30 g (1 oz) 30 g Tube Foot 30 g Carton Foot

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Lamisil AT Cream (this brand).

Top reported reactions

Pruritus75
Rash73
Nausea65
Fatigue61
Pain59
Dyspnoea54
Ageusia49

Age at onset

Infant1
Adult148
Elderly90

Reporter sex

1,241 reports
Male · 48%
Female · 51%
Unknown · 0%

Serious outcomes

Hospitalization326
Death49
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 155 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 1 tube (61047-0120-02), 1 tube (61047-0120-03). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Voyant Beauty Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 61046-0003-00 · Xellia 61047-0126-01 · Voyant →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.